Literature DB >> 35234914

CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis.

Souvik Ghosh1, Meric Ataman1,2, Maciej Bak1,2, Anastasiya Börsch1,2, Alexander Schmidt3, Katarzyna Buczak3, Georges Martin1, Beatrice Dimitriades1, Christina J Herrmann1,2, Alexander Kanitz1,2, Mihaela Zavolan1,2.   

Abstract

The mammalian cleavage factor I (CFIm) has been implicated in alternative polyadenylation (APA) in a broad range of contexts, from cancers to learning deficits and parasite infections. To determine how the CFIm expression levels are translated into these diverse phenotypes, we carried out a multi-omics analysis of cell lines in which the CFIm25 (NUDT21) or CFIm68 (CPSF6) subunits were either repressed by siRNA-mediated knockdown or over-expressed from stably integrated constructs. We established that >800 genes undergo coherent APA in response to changes in CFIm levels, and they cluster in distinct functional classes related to protein metabolism. The activity of the ERK pathway traces the CFIm concentration, and explains some of the fluctuations in cell growth and metabolism that are observed upon CFIm perturbations. Furthermore, multiple transcripts encoding proteins from the miRNA pathway are targets of CFIm-dependent APA. This leads to an increased biogenesis and repressive activity of miRNAs at the same time as some 3' UTRs become shorter and presumably less sensitive to miRNA-mediated repression. Our study provides a first systematic assessment of a core set of APA targets that respond coherently to changes in CFIm protein subunit levels (CFIm25/CFIm68). We describe the elicited signaling pathways downstream of CFIm, which improve our understanding of the key role of CFIm in integrating RNA processing with other cellular activities.
© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35234914      PMCID: PMC8989530          DOI: 10.1093/nar/gkac114

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  90 in total

1.  ERK Inhibition: A New Front in the War against MAPK Pathway-Driven Cancers?

Authors:  Inna Smalley; Keiran S M Smalley
Journal:  Cancer Discov       Date:  2018-02       Impact factor: 39.397

Review 2.  Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.

Authors:  S K Hanks; T Hunter
Journal:  FASEB J       Date:  1995-05       Impact factor: 5.191

Review 3.  Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

Authors:  Maria Ruzzene; Lorenzo A Pinna
Journal:  Biochim Biophys Acta       Date:  2009-08-06

4.  NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.

Authors:  Sheng Tan; Hua Li; Weijie Zhang; Yunying Shao; Yuan Liu; Haiyang Guan; Jun Wu; Yani Kang; Junsong Zhao; Qing Yu; Yunzhao Gu; Keshuo Ding; Min Zhang; Wenchang Qian; Yong Zhu; Huayong Cai; Changyu Chen; Peter E Lobie; Xiaodong Zhao; Jielin Sun; Tao Zhu
Journal:  Oncogene       Date:  2018-05-21       Impact factor: 9.867

5.  Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles.

Authors:  Takao Naganuma; Shinichi Nakagawa; Akie Tanigawa; Yasnory F Sasaki; Naoki Goshima; Tetsuro Hirose
Journal:  EMBO J       Date:  2012-09-07       Impact factor: 11.598

6.  Systematic profiling of poly(A)+ transcripts modulated by core 3' end processing and splicing factors reveals regulatory rules of alternative cleavage and polyadenylation.

Authors:  Wencheng Li; Bei You; Mainul Hoque; Dinghai Zheng; Wenting Luo; Zhe Ji; Ji Yeon Park; Samuel I Gunderson; Auinash Kalsotra; James L Manley; Bin Tian
Journal:  PLoS Genet       Date:  2015-04-23       Impact factor: 5.917

Review 7.  ERK/MAPK signalling pathway and tumorigenesis.

Authors:  Yan-Jun Guo; Wei-Wei Pan; Sheng-Bing Liu; Zhong-Fei Shen; Ying Xu; Ling-Ling Hu
Journal:  Exp Ther Med       Date:  2020-01-15       Impact factor: 2.447

8.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

9.  CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.

Authors:  Chioniso P Masamha; Zheng Xia; Jingxuan Yang; Todd R Albrecht; Min Li; Ann-Bin Shyu; Wei Li; Eric J Wagner
Journal:  Nature       Date:  2014-05-11       Impact factor: 49.962

10.  Prevention of dsRNA-induced interferon signaling by AGO1x is linked to breast cancer cell proliferation.

Authors:  Souvik Ghosh; Joao C Guimaraes; Manuela Lanzafame; Alexander Schmidt; Afzal Pasha Syed; Beatrice Dimitriades; Anastasiya Börsch; Shreemoyee Ghosh; Nitish Mittal; Thomas Montavon; Ana Luisa Correia; Johannes Danner; Gunter Meister; Luigi M Terracciano; Sébastien Pfeffer; Salvatore Piscuoglio; Mihaela Zavolan
Journal:  EMBO J       Date:  2020-08-19       Impact factor: 11.598

View more
  2 in total

Review 1.  Context-specific regulation and function of mRNA alternative polyadenylation.

Authors:  Sibylle Mitschka; Christine Mayr
Journal:  Nat Rev Mol Cell Biol       Date:  2022-07-07       Impact factor: 113.915

2.  Distinct, opposing functions for CFIm59 and CFIm68 in mRNA alternative polyadenylation of Pten and in the PI3K/Akt signalling cascade.

Authors:  Hsin-Wei Tseng; Anthony Mota-Sydor; Rania Leventis; Predrag Jovanovic; Ivan Topisirovic; Thomas F Duchaine
Journal:  Nucleic Acids Res       Date:  2022-08-22       Impact factor: 19.160

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.